Anal HPV prevalence and associated factors among HIV-seropositive men under antiretroviral treatment in Brazil

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue SUPPL. 3, 2011, Pages

  Guimarães, Mark Drew Crosland ^a   Grinsztejn, Beatriz ^b   Melo, Victor Hugo ^a   Rocha, Gustavo MacHado ^c   Campos, Lorenza Nogueira ^d   Pilotto, José Henrique ^b,e   Carmo, Ricardo Andrade ^d   Palefsky, Joel M ^f  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO JOÃO DEL REI   (Brazil)

^d Eduardo de Menezes Hospital   (Brazil)

^e Nova Iguacxu Hospital   (Brazil)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

anal HPV infection; HIV seropositive men; urban Brazil

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANAL CANAL; ANUS CANCER; ARTICLE; BRAZIL; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LOGISTIC REGRESSION ANALYSIS; MALE; MULTICENTER STUDY; PARTICIPANT OBSERVATION; PRIORITY JOURNAL; SEXUAL INTERCOURSE; VIRUS INFECTION; WART VIRUS;

ADULT; ANAL CANAL; BRAZIL; CROSS-SECTIONAL STUDIES; DNA, VIRAL; GENOTYPE; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MOLECULAR TYPING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; URBAN POPULATION;

EID: 79960754169     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31821e9994     Document Type: Article

References (25)

1. Parkin DM, Bray F, Ferlay J et al. Global cancer statistics, 2002. Cancer J Clin. 2005;55:74-108. (Pubitemid 40372904)
2. Chin-Hong PV, Palefsky JM. Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis. 2002;35:1127-1134. (Pubitemid 35239474)
3. de Pokomandy A, Rouleau D, Ghattas G, et al. Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. J Infect Dis. 2009;199:965-973.
4. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97:425-432. (Pubitemid 40528605)
5. D'Souza G, Wiley DJ, Li X, et al. Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr. 2008;48:491-499.
6. Piketty C, Selinger-Leneman H, Grabar S, et al. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS. 2008;22: 1203-1211.
7. Hoots BE, Palefsky JM, Pimenta JM, et al. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer. 2009;124;2375-2383.
8. Chin-Hong PV, Berry JM, Cheng SC, et al. Comparison of patient-and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men. Ann Int Med. 2008;149:300-306.
9. Palefsky JM, Holly EA, Ralston ML, et al. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis. 1998;177:361-367. (Pubitemid 28063760)
10. Piketty C, Darragh TM, Da Costa M, et al. High prevalence of anal Human Papillomavirus infection and anal cancer precursors among HIVinfected persons in the absence of anal intercourse. Ann Intern Med. 2003; 183:453-459.
11. Nyitray AG, Smith D, Villa L, et al. Prevalence of and risk factors for anal human papilloma virus infection in men Who have sex with women: a cross-national study. J Infect Dis. 2010;201:1498-1508.
12. Abramowitz L, Benabderrahmane D, Ravaud P, et al. Anal squamous intraepithelial lesions and condyloma in HIV-seropositive heterosexual men, homosexual men and women: prevalence and associated factors. AIDS. 2007;21:1457-1465. (Pubitemid 46988006)
13. McCloskey JC, Metcalf C, French MA, et al. The frequency of high-grade intraepithelial neoplasia in anal/perianal warts is higher than previously recognized. Int J STD AIDS. 2007;18:538-542. (Pubitemid 351738941)
14. Nielson CM, Harris RB, Dunne EF, et al. Risk factors for anogenital human papillomavirus infection in men. J Infect Dis. 2007;196:1137-1145. (Pubitemid 47580268)
15. Nielson CM, Harris R, Flores R, et al. Multiple-type Human Papillomavirus infection in male anogenital sites: prevalence and associated factors. Cancer Epidemiol Biomarkers Prev. 2009;18:1077-1083.
16. Palefsky JM, Holly E, Hogeboom CJ, et al. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:415-422.
17. Sirera G, Videla S, PinolM, et al. High prevalence of human papillomavirus infection in the anus, penis and mouth in HIV-positive men. AIDS. 2006;20: 1201-1204. (Pubitemid 43786111)
18. Orlando G, Tanzi E, Beretta R, et al. Human Papillomavirus genotypes and anal-related lesions among HIV-1 infected men in Milan, Italy. J Acquir Immune Defic Syndr. 2007;47:129-131.
19. Chaturvedi AK, Madeleine MM, Biggar RJ, et al. Risk of Human Papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst. 2009;101:1120-1130.
20. Pallela FJ, Deloria-Knoll M, Chmiel JS, et al. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann Intern Med. 2003;138:620-627.
21. Bower M, Powles T, Newsom-Davis T, et al. HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome? J Acquir Immune Defic Syndr. 2004;37:1563-565. (Pubitemid 39658192)
22. Wilkin T, Lee JY, Lensing SY, et al. Safety and immunogenicity of the quadrivalent Human Papillomavirus vaccine in HIV-1-infected men. J Infect Dis. 2010;202:1246-1253.
23. de Sanjose S, Diaz M, Castellsague X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7: 453-459. (Pubitemid 46962343)
24. Grinsztejn B, Veloso VG, Levi JE, et al. Factors associated with increased prevalence of human papillomavirus infection in a cohort of HIV-infected Brazilian women. Int J Infect Dis. 2009;13:72-80. Erratum in Int J Infect Dis. 2009;13:655-656.
25. Mbulawa ZZ, Coetzee D, Marais DJ, et al. Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection. J Infect Dis. 2009;199:1514-1524.